Spruce Biosciences BLA filing for rare disease drug on track for 2026
Go back to Spruce Biosciences BLA filing for rare disease drug on track for 2026| (NASDAQ: SPRB) | Delayed: 54.52 +1.47 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.05 | 52 Week High | $ | |||
| Open | $53.84 | 52 Week Low | $ | |||
| Day High | $55.06 | P/E | N/A | |||
| Day Low | $53.07 | EPS | $ | |||
| Volume | 66,027 | |||||
